Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.
The item "Capital-Expenditures" stands at 2.64 Billion Swiss Francs for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value at least since 12/31/2011, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -39.87 percent compared to the value the year prior.
The 1 year change in percent is -39.87.
The 3 year change in percent is -57.95.
The 5 year change in percent is -64.34.
The 10 year change in percent is -48.84.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Capital Expenditures | 905,699,262,464.00 |
![]() | Johnson & Johnson - Capital Expenditures | 486,508,953,600.00 |
![]() | AbbVie Inc - Capital Expenditures | 399,570,305,024.00 |
![]() | AstraZeneca PLC - Capital Expenditures | 280,205,508,085.11 |
![]() | Novartis AG - Capital Expenditures | 255,096,620,580.91 |